A Blueprint for Assessing Affordability of SGLT2 Inhibitors in the United States: The Cost-Effectiveness of Dapagliflozin in Three European Countries.
Annika KhineEugene LinPublished in: Clinical journal of the American Society of Nephrology : CJASN (2022)
Keyphrases